SCHEMBL7146307

SCHEMBL7146307

COC(C)c1ccc(-c2ccc(N)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 5/20 0.48
ALDH1A1 P00352 5/20 0.48
TP53 P04637 4/20 0.48
CYP3A4 P08684 3/20 0.48
AKR1C2 P52895 1/20 0.44
AKR1C1 Q04828 1/20 0.44
GRIA4 P48058 1/20 0.41
HSD17B10 Q99714 4/20 0.41
TAAR1 Q96RJ0 1/20 0.41
MAPK1 P28482 1/20 0.39
APP P05067 1/20 0.37
KDM4E B2RXH2 4/20 0.37
NPC1 O15118 4/20 0.37
RAB9A P51151 4/20 0.37
MAPT P10636 4/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
PRKAB2 O43741 1/20 0.36
PRKAG1 P54619 1/20 0.36
PRKAA2 P54646 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13450978 0.93 TDP1 (0.44) TDP1ALDH1A1TP53CYP3A4AKR1C2
SCHEMBL31508194 0.93 TDP1 (0.44) TDP1ALDH1A1TP53CYP3A4AKR1C2
SCHEMBL4921245 0.93 TDP1 (0.44) TDP1ALDH1A1TP53CYP3A4AKR1C2
SCHEMBL7140178 0.81 TAAR1 (0.46) TDP1ALDH1A1TP53CYP3A4AKR1C2
SCHEMBL1338710 0.81 AKR1C2 (0.42) TDP1ALDH1A1AKR1C2AKR1C1MAPK1
SCHEMBL8750554 0.80 PTGS2 (0.50) ALDH1A1AKR1C2AKR1C1
SCHEMBL8750439 0.79 IDO1 (0.43) ALDH1A1AKR1C2AKR1C1MAPK1KDM4E
SCHEMBL256589 0.79 ALDH1A1 (0.61) TDP1ALDH1A1TP53CYP3A4GRIA4
SCHEMBL25628480 0.78 MAPK1 (0.50) TDP1ALDH1A1TP53AKR1C2AKR1C1
SCHEMBL9547833 0.78 AKR1C2 (0.51) TDP1CYP3A4AKR1C2AKR1C1APP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0789577-B1 SYNTHESIS OF N-SUBSTITUTED OLIGOMERS CHIRON CORP (US) 2003-03-12 EP disclosed
EP-0671928-B1 SYNTHESIS OF N-SUBSTITUTED OLIGOMERS CHIRON CORP (US) 2002-11-27 EP disclosed
EP-1258492-A1 N-substituted oligomers and methods for their synthesis, e.g. polyglycine bearing nucleic acid bases CHIRON CORPORATION (US) 2002-11-20 EP disclosed
US-5977301-A AUTOMATED AND EFFICIENT SYNTHESIS BY REACTING SOLID SUPPORT BOUND AMINE WITH AN ACYLATING SUBMONOMER TO PRODUCE A SOLID SUPPORT-BOUND AMIDE WHICH CAN BE FURTHER REACTED; ONLY REACTIVE SIDE CHAINS NEED PROTECTED CHIRON CORPORATION (US) 1999-11-02 US disclosed
US-5877278-A SOLID PHASE SYNTHESIS USING TWO SUBMONOMERS-AN ACYLATING AGENT, E.G. A HALOACETIC ACID, AND A PRIMARY AMINE; CYCLIZATION TO PRODUCE MIMETICS OF DRUGS; ELIMINATION OF THE NECESSITY OF PROTECTION GROUPS CHIRON CORPORATION (US) 1999-03-02 US disclosed
US-5831005-A ACYLATION, NUCLEOPHILIC DISPLACEMENT CYCLES CHIRON CORPORATION (US) 1998-11-03 US disclosed
US-5480871-A TREATMENT OF BENIGN PROSTATIC HYPERPLASIA CHIRON CORPORATION (US) 1996-01-02 US disclosed
US-5447916-A Hypotensive agents CHIRON CORPORATION (US) 1995-09-05 US disclosed
WO-1995004072-A1 PEPTOID ALPHA-1 ADRENERGIC RECEPTOR LIGANDS CHIRON CORPORATION (US) 1995-02-09 WO disclosed